About MedPharm
MedPharm is a company based in Guildford (United Kingdom) founded in 1998 by Marc Brown. The company has 108 employees. MedPharm offers products and services including Formulation Development, In Vitro Testing, Commercial Production, and Analytical Methods. MedPharm operates in a competitive market with competitors including Jubilant Life Sciences, Recipharm, Akums, Unither and Nectar Lifesciences, among others.
- Headquarter Guildford, United Kingdom
- Employees 108
- Founders Marc Brown
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website medpharm.com
- Social LinkedIn X
- Legal Name Medpharm Limited
- Date of Incorporation 07 Jun, 1999
- Jurisdiction GUILDFORD, SURREY
- Annual Revenue$26.7 M (USD)9as on Dec 31, 2021
- Net Profit-$154.57 K (USD)-118as on Dec 31, 2021
- EBITDA$82.81 K (USD)-92as on Dec 31, 2021
- Investors
- Employee Count108
Products & Services of MedPharm
MedPharm offers a comprehensive portfolio of products and services, including Formulation Development, In Vitro Testing, Commercial Production, and Analytical Methods.
Service for creating and testing pharmaceutical formulations.
Testing methods to evaluate drug efficacy and safety.
Production of topical drugs for market supply.
Development of methods for drug analysis and bioequivalence.
Funding Insights of MedPharm
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of MedPharm with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2018 | – | Private Equity Round | – | – |
1 investors in total: 1 institutional.
Investors in MedPharm
MedPharm has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Ampersand Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Ampersand Capital Partners is focused on investments in healthcare and life sciences. | – | ampersandcapital.com | Boston, United States |
Investor details for MedPharm
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of MedPharm
1 people are tracked at MedPharm (1 in leadership); the tracked headcount is 108.
| Name | Role | Group |
|---|---|---|
Marc Brown | Co-Founder & CSO | Leadership |
Complete people profiles for MedPharm
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of MedPharm
2 dated milestones of MedPharm across 20 years, from founding to its latest funding, stage changes and deals.
- Founded MedPharm is founded.
- Funding First funding round.
Competitors of MedPharm
MedPharm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jubilant Life Sciences, Recipharm, Akums, Unither and Nectar Lifesciences, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| jubl.com | 1978 | Noida, India | – | – | Company offering a suite of R&D and manufacturing services for small molecules and generics | |
| recipharm.com | 1995 | Jordbro, Sweden | – | 1,083 | Pharmaceutical development and manufacturing services are offered contractually. | |
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| unither-pharma.com | 1993 | Paris, France | – | – | Contract development and manufacturing organization for proprietary and generic drugs | |
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. | |
| corerxpharma.com | 2006 | Clearwater, United States | $15M | – | CDMO with a focus on early phase drug product development | |
| windlas.com | 2001 | Gurugram, India | $12.96M | 1,264 | Biopharma regulatory affairs, quality control, and strategy services are provided. | |
| zambon.com | 1906 | Bresso, Italy | – | – | APIs and finished drugs are developed and manufactured in pharmaceuticals. | |
| aenova-group.com | 2008 | Starnberg, Germany | – | – | CDMO services for pharmaceuticals, medical devices, and nutraceuticals are provided. | |
| leukocare.com | 2003 | Munich, Germany | $17.5M | 70 | Proprietary stabilizing solutions for biologics formulations are developed. |
Detailed competitors of MedPharm
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of MedPharm
The website of MedPharm (medpharm.com) receives about 5.3K visits a month and ranks #6,145,162 among all websites worldwide, #6,437 in Biotechnology and Pharmaceuticals.
- Monthly visits5.3K
▲ 79.8% vs previous month
- Unique visitors1.2K
per month
- Global rank#6,145,162
among all websites
- Category rank#6,437
Health · Biotechnology and Pharmaceuticals
- Bounce rate38%
- Pages per visit1.4
- Average visit5 sec
- DevicesDesktop 28% · Mobile 72%
Websites whose visitors overlap most with MedPharm. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| maynepharma.com | 100% | 18.6K | #918,677 | View details | |
| salix.com | 98% | 15.6K | #1,433,848 | View details | |
| indivior.com | 93% | 33.3K | #1,007,938 | View details | |
drug-dev.com | drug-dev.com | 82% | – | #896,353 | – |
merzusa.com | merzusa.com | 72% | – | #2,673,211 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 12 similar websites and full traffic analytics for MedPharm
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Medpharm
Complete news archive for MedPharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to MedPharm
10 companies that operate in the same segment as MedPharm (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about MedPharm
MedPharm was founded in 1998 and raised its 1st funding round 20 years after it was founded.
MedPharm is headquartered in Guildford, United Kingdom.
MedPharm has 108 employees.
Annual revenue of MedPharm is $26.7M as on Dec 31, 2021.
MedPharm was founded in 1998 in Guildford, United Kingdom, within the pharmaceutical sector. Operations center on topical and inhaled drug delivery methods, including MedSpray for aerosol-based mucosal films, MedTherm for thermogenic transdermal systems, and AquaRMed for humectant-enhanced bioavailability. Services encompass process development, formulation, performance testing, and clinical supply manufacturing, with emphasis on API and formulation production.
MedPharm's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
MedPharm offers Formulation Development, In Vitro Testing, Commercial Production, and Analytical Methods.
MedPharm has 1 investor. Key investors include Ampersand Capital Partners.
MedPharm operates through Medpharm Limited.